Among OPT pesticides, malathion is considered relatively safe for use in mammal. Its rapid degradation by carboxylesterases competes with the CYP-catalyzed formation of malaoxon, the toxic metabolite. However, impurities in commercial formulations are potent inhibitors of carboxylesterase, allowing a dramatic increase in malaoxon formation. Malathion desulfuration has been characterized in human liver microsomes (HLM) with a method based on AChE inhibition, able to detect nM levels of oxon. The active CYPs have been identified by means of a multifaceted strategy, including the use of c-DNA expressed human CYPs, correlation, immuno-and chemical inhibition studies in a panel of phenotyped HLM. HLM catalyzed malaoxon formation with a high level of variability (>200 fold). One or two components (K mapp1 =53-67µM; K mapp2 =427-1721µM) were evidenced, depending on the relative specific CYP content. Results from different approaches indicated that, at low malathion concentration, malaoxon formation is catalyzed by CYP1A2 and to a lesser extent 2B6, while the role of 3A4 is relevant only at high malathion levels. These results are in line with those found with chlorpyrifos, diazinon, azynphos-methyl and parathion, characterized by the presence of an aromatic ring in the molecule. Since malathion has linear chains as substituents at the thioether sulphur, it can be hypothesized that, independently from the chemical structure, OPTs are bioactivated by the same CYPs. These results also suggest that CYP1A2 and 2B6 can be considered as possible metabolic biomarkers of susceptibility to OPT-induced toxic effects at actual human exposure levels.
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major pathway of malathion metabolism is the cytochrome P450-catalyzed bioactivation, resulting in a dramatic increase in the production of malaoxon.
In recent years a number of papers have been published on the activity of human CYPs involved in the biotransformation of some members of OPT class (Buratti et al., 2002; Buratti et al., 2003; Butler and Murray, 1997; Kappers et al., 2001; Mutch et al., 1999; Tang et al., 2001; Vittozzi et al., 2001) . It has been demonstrated with human liver microsomes and recombinant human CYPs, that at low pesticide concentrations (<10 µM), azinphos-methyl, chlorpyrifos, diazinon and parathion are mainly desulfurated by CYP1A2 (Buratti et al., 2002; Buratti et al., 2003) . The role of CYP2B6 to total hepatic oxon formation seemed to be relevant in a wide range of pesticide concentrations, (Buratti et al., 2003; Tang et al., 2001) , while the contribution of CYP3A4 resulted significant only at high OPT levels (Buratti et al., 2002; Buratti et al., 2003; Kappers et al., 2001; Mutch et al., 1999) .
No information is available on human malathion bioactivation, despite its widespread use makes potential for human exposure high, both for agriculture workers and for general population. Exposure may be relevant especially among children (Adgate et al., 2001; Fenske et al., 2000; Fenske et al., 2002) , exposed to excess dietary intake caused by food-to-surfaceto-mouth or surface-to-hand-to-food activities (Melnyk et al. 2000) . Only limited data have been reported on malathion carboxylesterase activity in human liver (Talcott et al. 1979a) .
We have undertaken this study in order to characterize malathion bioactivation in the human liver and to provide data on the role of human CYPs in the formation of toxic metabolites. In order to study low pesticide concentrations, representative of actual human exposure, we took advantage of a method based on AChE inhibition, able to detect nM levels of oxon (Buratti et al., 2002; Ma and Chambers, 1994) .
The OPTs, whose human bioactivation has been studied so far, were characterized by the presence of aromatic rings in the molecule; the similar chemical structure may be the main DMD#1693R
MATERIALS AND METHODS

Chemicals
Malathion (purity 99%) and malaoxon (purity 88%) were obtained from Chem Service (West Chester, PA). Roche GmBh (Mannheim, Germany) supplied NADPH, NADP, glucose-6-phosphate and glucose-6-phosphate-dehydrogenase (G6PDH). Triton-X-100, dithiobisnitrobenzoic acid (DTNB) and acetylthiocholine were purchased from Fluka (Buchs, Switzerland). Tetraisopropyl-pyrophosphoramide (iso-OMPA), isoform-selective cytochrome P450 inhibitors furafylline, troleandomycin, orphenadrine, caffeine and paraxantine were supplied by Sigma (St. Louis, MO). Defatted bovine serum albumin was obtained from Serva, Feinbiochemica (Heidelberg, Germany). Dextrometorphan, 3-methoxymorphinan, Smephenytoin, nirvanol, S-4-hydroxymephenytoin, and antihuman CYP1A2, 1A1, 2A6, 2B6, 2D6, 2E1, 3A4 antibodies (Ab) for immunoinhibition studies were purchased from BDGentest TM (Worburn, MA); according to the supplier, Abs show no crossreactivities one to another.
All other analytical grade chemicals were obtained from commercially available sources.
Animals, recombinant human CYP and human liver microsomes (HLM)
Sprague-Dawley rats weighing 150-200 g were purchased from Charles River (Calco, Italy).
The animals were maintained in air-conditioned room and were allowed free access to standard chow and tap water for a week before starting the experiment. Rats were killed by decapitation and their whole brain was immediately taken. The European Community Council Directive (86/609/EEC) and Italian National rules on animal care and use have been followed. preparations was in the range of 3.8 -12 mg/ml; cytochrome P450 content, determined by the supplier, was 1 nmol P450/ml.
HLM were prepared from a single liver sample (HLM 2 ), kindly gifted by the University of Washington (Seattle, WA) (Buratti et al., 2003) . (Krul and Hageman, 1998; Heyn et al., 1996; Easterbrook et al., 2001; Chen et al., 1990) . These marker activities for individual HLM used in the characterization of malathion bioactivation and in inhibition studies are reported in Table 2 .
Preparation of soluble Acetylcholinesterase (AChE)
Extraction of the enzyme was carried out as described in Meneguz et al. (1989) with minor modification. Briefly, brain was homogenized at 4°C in 0.038 M Tris-HCl buffer, pH 8.5, (tissue/buffer ratio 1:10). The homogenate was centrifuged at 100000 g for 60 minutes at 4°C
to obtain a cytosolic supernatant containing the AChE soluble form. AChE activity was determined in each preparation by the method of Ellman et al. (1961) and was in the range 0.5-1 mmol acetylthiocholine hydrolysed · (min · g tissue) -1 .
Malaoxon production from malathion
Enzymatic incubation. The standard incubation mixture (0.5 ml) contained: 2mM glucose-6-This article has not been copyedited and formatted. The final version may differ from this version. (corresponding to 1-1.5 µmol acetylthiocholine hydrolysed/min) were added, followed by the addition of malathion as 10 µl methanolic solution at different concentrations, in order to obtain substrate final concentration in the range 0.01-50 µM malathion. The mixture was preincubated at 37°C for 3 min before starting the reaction by adding SUPERSOMES (25-50 pmol P450/ml). CYP2E1 could not be tested, due to the strong inhibitory effect exerted on this recombinant isoform by very low levels of organic solvents, including methanol, in which malathion was dissolved. Different CYP concentrations (10, 25, 40, 50, 100 pmol P450/ml) and incubation times (1, 2, 3, 5, 10 min) were used in preliminary studies in order to verify the linearity of the reaction vs enzyme concentration and time. When incubations with HLM were carried out, the standard incubation mixture contained 0.3-1 mg protein/ml and 50 µM iso-OMPA, added in order to inhibit nonspecific esterases, whose presence was assessed in standard incubations carried out in the absence of both AChE and pesticide. The optimal inhibiting conditions to be used (i.e. iso-OMPA concentration and time of preincubation) were previously determined (Buratti et al., 2003) . The mixture was preincubated at 37°C for 15 min; then 15-20 µl AChE were added and the reaction was started with 10 µl malathion methanolic solution (10-500 µM malathion as final concentration). Different protein concentrations (0.2, 0.4, 0.5, 0.7 and 1 mg/ml) and incubation times (1, 2, 5, 10, 20 min) were used in preliminary studies in order to verify the linearity of the reaction vs enzyme concentration and time.
The enzymatic incubations both with SUPERSOMES and HLM were carried out at 37°C under shaking (80 cycles/min) and stopped after 2 min by adding 0.5 ml cold incubation buffer, containing 8% Triton-X-100. Controls and blanks were carried out in parallel with corresponding samples. Controls differed from samples for the presence of SUPERSOMES 
Correlation studies
Oxon formation from malathion was determined in standard incubations with 16 individual HLM, fully characterized for single CYP activities. They were selected in order to have a broad range of activity for all the different cytochrome P450 isoform. Malathion was tested at 2 pesticide concentrations (50µM and 400µM). Correlation coefficients were calculated by plotting the rate of malaoxon formation vs the marker activity of each CYP.
Immunoinhibition of malaoxon formation
The immunoinhibition studies were carried out at 50µM and 400µM malathion with three Blanks differed from controls and samples for the absence of acetylthiocholine.
Chemical inhibition of malaoxon formation
Isoform-selective cytochrome P450 inhibitors were added to the standard incubation mixture based inhibitor with NADPH-generating system at 37°C for 15 min. Then the standard procedure for malaoxon formation and detection was followed. In a separate set of experiments the standard incubation mixture was preincubated in the simultaneous presence of the three inhibitors, in order to evaluate the additivity of their inhibitory effects at two malathion concentrations (50 and 400 µM).
Two kind of controls (A and B) and blanks were carried out in parallel with corresponding samples. In Control A the presence of inhibitors was replaced by Tris buffer or solvent, and was set as 100% metabolic activity. Control B contained the inhibitor but not NADP and was set as 100% cholinergic activity. Blanks differed from controls and samples for the absence of acetylthiocholine.
Data analysis
The kinetic 
RESULTS
In vitro malathion bioactivation by c-DNA expressed human CYPs
Preliminary studies. The absence of nonspecific esterases in SUPERSOMES preparations, that could interfere with AChE activity determination, has been previously shown (Buratti et al., 2002) . The direct inhibition of AChE activity, due to unmetabolized malathion or impurities, was measured in standard incubations of control SUPERSOMES in the absence of NADP. Malathion did not affect AChE activity up to 50 µM, the highest pesticide concentration tested. When malaoxon formation was tested at different incubation time and CYP concentration, the standard experimental condition used resulted in the linear range of the reaction: indeed the reaction was linear up to 5 minutes and 100 pmol P450/ml (data not shown).
Kinetic parameters of malaoxon formation. CYP2C19, 1A2 and 2B6 were very efficient in catalyzing malathion sulfoxidation. Indeed, in standard incubations containing 50 pmol P450/ml, the levels of malaoxon produced overwhelmed the levels of AChE, reaching 100%
inhibition. Therefore, to test malaoxon formation in the range 0.01-2.5µM malathion, it was necessary to reduce to 1/2 the CYP content in standard incubation. The dependence of CYP2C19, 1A2 and 2B6 activity on malathion concentration was represented by typical saturation curves (data not shown). CYP2C19 showed the highest affinity toward malathion (corresponding to the lowest K m ) and the highest V max for malaoxon production ( Table 1 ).
The ranking of intrinsic clearance (CL i ) values was 2C19>1A2>2B6 (Table 1) . CYP1A1 activity deviated from linearity only at the highest malathion concentration used (50µM), while CYP3A4, 2C8 and 2C9 were still linear up to this concentration (data not shown): they all were endowed with very low CL i values (Table 1 ). CYP2D6 and 2A6 were not able to catalyze any malathion desulfuration even at the highest pesticide concentration tested.
To preliminarily estimate the relative contribution of different CYPs to malaoxon formation, a accounted for >80% of the reaction, whereas CYP2C19 and 2B6, due to their lower hepatic content, were responsible for 14 and 1.6%, respectively (Table 1) . When V max or V data obtained at 50 µM malathion were used, it appeared that the contribution of CYP3A4 was greatly increased and similar to CYP1A2 (43% and 40%, respectively) (data not shown),
suggesting that the catalytic activity of 3A4 may become relevant with increasing pesticide concentrations.
In vitro malathion bioactivation by HLM
Preliminary studies. The presence of esterase activity in all the tested HLM, measured as acetylthiocholine hydrolysis, varied in the panel of sample used (range 0.92-3.84 µmol acetylthiocholine hydrolyzed/min). The addition of 50 µM iso-OMPA to the incubation mixture (Buratti et al., 2003) completely inhibited nonspecific esterase activity, preventing the interference with AChE activity determination. The direct inhibition of AChE activity, possibly due to unmetabolized malathion or to impurities of the commercial product, was tested carrying out standard incubations with HLM in the absence of NADP. Malathion did not affect AChE activity up to 100µM; at concentrations > 200 µM the inhibition was <12%.
Therefore, ad hoc control incubations in the absence of NADP were run in parallel. The standard experimental conditions used for malaoxon production resulted in the linear range of dependence of the reaction with respect to both incubation time and protein concentrations:
indeed, the reaction was linear up to 1 mg protein/ml and 10 min incubation time (data not shown). With both HLM 1 and HLM 2 , endowed with 2-3 fold higher levels of CYP1A2-related activity with respect to the other two samples (Table 2 ), malathion desulfuration was described by saturation curves ( Fig. 2A) . Data of malaoxon production by both HLM 1 and HLM 2 , fitted two straight lines in the Eadie-Hofstee plot, indicating that two distinct components with different affinities, each of them catalyzed by one or more isoforms, are involved in the desulfuration reaction ( Fig. 2A) , giving rise to different kinetic parameters (Table 3 ). The high affinity phase appeared to deviate from linearity at about 100 µM malathion and it was characterized by similar K mapp1 in the two samples (53-67 µM). However, the efficiency (CL i1 ) of the reaction differed between the two samples, depending on the 10-fold higher V maxapp1 expressed by HLM 2 (Table 3) . The low affinity phase was not yet saturated at 500 µM malathion in both HLM and the kinetic parameters K mapp2 and CL i2 were highly variable.
The two HLM, characterized by similar scant levels of CYP2C19 (CYP1A2-to-CYP2C19 was 10 and 18.5, respectively) and by comparable CYP3A4-related activity, differ only in CYP2B6 content, which was higher in HLM 2 (Table 2 ). In HLM 3 and HLM 4 , having low CYP1A2 content, only one component was evident: malathion desulfuration activity resulted linear up to 500 µM malathion (Fig. 2B) . HLM 3 endowed with efficient CYP2B6-, 3A4-and 2C19-marker activity (Table 2) , produced malaoxon levels similar to HLM 2 (Fig. 2) , whereas
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Correlation studies
Correlation studies were carried out measuring malaoxon formation in incubations with HLM from 16 individual donors. Malathion concentrations (50 and 400 µM) were selected on the basis of the calculated K mapp values (Table 4) ) (mean+SD= 399+254) (Table 4) .
When malaoxon formation was plotted vs each marker activity for single CYPs, only CYP1A2, 3A4 and 2B6 related activities showed significant correlation (Table 4) . Caffeine N3-demethylation was the only activity correlating with malaoxon formation at 50 µM malathion (R=0.722). At 400 µM malathion the same correlation was no more evident. On the other hand, at high pesticide concentration, CYP2B6 and 3A4 marker activities showed very high correlation coefficients (R=0.902 and R= 0.828, respectively) ( Table 4) .
Immunoinhibition studies
Results from immunoinhibition studies with 3 different HLM samples (HLM 1 , HLM 2 and HLM 5 ) indicated that anti-CYP1A2, 3A4 and 2B6 Abs were responsible for significant inhibition in malaoxon formation (Table 5 ).
This article has not been copyedited and formatted. The final version may differ from this version. A different pattern of inhibition was evident when the two malathion concentrations were tested, indicating that different CYPs are involved in the low and the high affinity phase of the desulfuration reaction. Indeed, at 50 µM malathion the addition of antiCYP1A2 Ab caused a strong inhibition of malaoxon formation when the 3 individual HLM were tested (less than 30% residual activity). In HLM 2 , although the CYP1A2-to-CYP2B6 ratio (0.68) was similar to the one in HLM 5 and HLM 1 (0.53 and 0.34, respectively) also antiCYP2B6 Ab addition to the mixture had a significant inhibitory effect on malathion desulfuration (about 30% residual activity) (Table 5) , probably due to the higher S-mephenytoin N-demethylation activity in this sample (Table 2 ). When 400 µM malathion was incubated in the presence of each single Ab, either antiCYP3A4 Ab or antiCYP2B6 Ab were responsible for a substantial inhibition of malathion desulfuration (50-70%) with the three HLM (Table 5) , whereas antiCYP1A2 Ab did not affect malaoxon formation.
When the three Abs, singularly active in preventing malaoxon formation, were simultaneously added to the incubation mixture, the range of residual activity was 16-27% at 50 µM and 7-12% at 400 µM malathion (Table 5) . These results suggested a moderate-tonegligible contribution to the reaction by CYPs other than the inhibited ones.
Chemical inhibition studies
Single chemical specific CYP-inhibitors were incubated with three individual HLM used for the characterization of malathion bioactivation at different pesticide concentration (range10-500 µM malathion) (Fig.3) .
When orphrenadrine was used with HLM 1 and HLM 2 , no inhibition was measured up to 100 µM malathion, whereas the low affinity phase disappeared (Fig. 3A e B furafylline was used, no malaoxon formation was detectable up to 50-100 µM malathion (inhibition >90%); at higher malathion concentration the activity was much lower than the one measured in the absence of the inhibitor (20-50% residual activity). With HLM 3 orphrenadrine showed a pattern of inhibition similar to the one described in the other 2 samples (Fig 3C) , whereas furafylline had no effect on HLM 3 activity (data not shown), consistently with the very low levels of CYP1A2 present in that sample. The effect of troleandomycin was scant and not statistically significant in HLM 1 and HLM 2 (data not shown), whereas it resulted a quite efficient inhibitor (about 50% residual activity) in HLM 3
( Fig. 3C ) at malathion concentrations higher than 200 µM.
The simultaneous presence of the three inhibitors, specific for CYP1A2, 2B6 and 3A4, caused an almost complete inhibition of malaoxon formation both at 50 and 400 µM malathion, with a residual activity of 4.8 and 2.6%, respectively, suggesting a negligible contribution to the reaction by other CYPs.
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DISCUSSION
In this paper, we reported the characterization of malathion desulfuration in HLM within a broad range of concentrations (0.1-500 µM). The study has been carried out with a multifaceted integrated experimental strategy: the enzyme specificity obtained by using recombinant CYPs has been paralleled by the kinetics characterization of the reaction in HLM. These data, corroborated by results from correlation, chemical and immuno-inhibition studies, have allowed the identification of CYPs involved in malathion bioactivation in the human liver.
The use of in vitro concentrations close to the actual human exposure levels is crucial to obtain data relevant to the in vivo situation. It has been suggested that in vitro concentrations of OPTs <10µM are the most appropriate to mimic in vivo conditions (Buratti et al., 2002 and 2003) , based on chlorpyrifos plasma concentrations (90 nM) measured in human volunteers (Nolan et al., 1984) and on the estimation of environmental exposure in US adults and children (about 1.4-1.61 µg/kg/day) (Rigas et al., 2001; Schurdut et al., 1998) , obtained by applying pharmacokinetic models to biomonitoring data. On the same line, starting from urinary alkylphosphate levels, a body burden of 208 µg/kg azinphos-methyl (corresponding to 6.5 µM in plasma) was estimated in orchard workers at the steady state (Carrier and Brunet, 1999) . Similar conclusions may be drawn for malathion: it has been reported that in the urine of general US adult population, malathion mono-acid is detectable up to 3 µM (Kutz et al., 1992) , whereas in children the mean content was about 4.5 nM (range=3-28 nM) (Adgate et al., 2001) . Higher values were reported in tissues, urine or plasma of workers who applied the insecticide or harvested the crops; their exposure was estimated to be 1-3 mg/kg/day and 1-270 µg/kg/day, respectively (Krieger and Dinoff, 1999) , which may give rise to a range of plasma concentrations between 0.03 and 80 µM, considering an almost complete absorption.
Since in vivo hepatic concentrations are usually higher than circulating ones, malathion Values of kinetic parameters obtained with recombinant CYPs clearly indicated that CYP2C19, 1A2 and 2B6 are very efficient in malaoxon formation, detectable starting from 0.1µM OPT. In these conditions, the contribution of CYP3A4, 1A1, 2C8 and 2C9 was negligible; their activity could be more relevant at high substrate concentrations, being linear up to 50µM malathion. CYP2A6 and 2D6 were not able to catalyze malathion bioactivation.
The relative contribution calculated to take into account the average content of each CYP in an ideal human liver, suggested a pivotal role in malaoxon formation for CYP1A2 at low pesticide concentrations, and a substantial contribution of CYP3A4 at higher malathion levels.
Much of these qualitative data were confirmed by using HLM, where the different isoforms are concurrently present and compete one to another for the substrate. Within the tested panel, malathion was efficiently bioactivated and HLM were able to produce substantial amount of malaoxon, although with a high level of interindividual variability (>200 fold). Kinetic characterization of malathion desulfuration in four different HLM showed that one or two components with different affinity for the pesticide were present, depending on the relative specific CYP content and indicating the involvement of multiple CYPs. The presence of two phases in oxon formation has been previously shown with other OPTs both with human (Buratti et al., 2003) and rat (Ma and Chambers, 1994) liver microsomes, when a low-to-high range of pesticide concentrations was tested. The similarity of the K mapp (K mapp1 = 53-67 µM), 1A2 activity (ratios= 28, 26 and 17, respectively), the reaction consisted of only one phase, linearly dependent on malathion concentration up to 400 µM, although high amount of malaoxon were produced. In addition, at 50µM malathion, representative of the high affinity phase, malaoxon formation correlated only with CYP1A2-related activity and was dramatically inhibited by antiCYP1A2 Ab in 3 HLM. In the presence of furafylline, the high affinity phase was no more evident in the kinetics of malaoxon formation vs malathion concentration in HLM 1 and HLM 2 , when malaoxon was undetectable at malathion <50-100 µM. The low affinity phase seemed to be not significantly affected by furafylline, indicating a limited contribution of CYP1A2 at high pesticide concentrations, as also suggested by no correlation between malaoxon formation and CYP1A2 and no inhibition by antiCYP1A2 Ab at 400 µM malathion. The immunoinhibition measured in HLM 2 with antiCYP2B6 Ab, and the inhibitory effect of orphrenadrine in HLM 3 at low malathion concentrations seems to suggest some involvement of this CYP to the high affinity phase, likely relevant only when CYP2B6 is highly expressed, or CYP1A2 content is scant, as in the case of the tested samples.
The low affinity component of malathion bioactivation was not saturated up to 500 µM pesticide in the tested samples; coherent results from the different approaches, indicated CYP2B6 and 3A4 as the major responsible for malaoxon formation. Results from the kinetic analysis in HLM 2 and HLM 3 , showed that, when these two isoforms are present at high levels, the CL i related to the low affinity phase is significantly higher (15.5 and 8.0 µl· mg prot considered the role of CYP2C19 relevant in OPT dearylation rather than in oxon formation (Buratti et al., 2003; Tang et al., 2001; Vittozzi et al., 2001) ; others suggested some involvement only when hepatic content of CYP2C family is extremely high, with a simultaneous low CYP3A4 level (Mutch et al., 1999) , whereas it has been considered as the major catalyst for diazoxon production at diazinon high concentrations (Kappers et al., 2001 ).
However, the lack of a selective chemical inhibitor either of monoclonal antiCYP2C19 Ab, makes it difficult to conclude a role for this isoform, although the whole body of results indicates a scant contribution to malathion bioactivation.
Differently from the limited action of human hepatic paraoxonase at low level of oxon, due to its K m value (0.29mM) (Gonzalvo et al., 1998) , human carboxylesterase seems to be quite efficient in detoxifying malathion (USEPA, 2000) . Moreover, cytochrome P450 itself may contribute to malathion detoxication, catalyzing DMDTP formation (Fig.1) . Therefore, the bioactivation/detoxication balance may be the crucial step in determining differences in This article has not been copyedited and formatted. The final version may differ from this version. malathion-induced toxicity. However, since carboxylesterase can be strongly inhibited by isomalathion and other impurities (Aldridge et al., 1979; Talcott et al., 1979a and 1979b) , differences in malaoxon production due to different pheno/genotypes can be relevant in interindividual response to toxic effects consequent to malathion exposure.
The present results showed the involvement of CYP1A2 in malaoxon formation at low malathion concentration, representative of conditions of actual human exposure, whereas CYP2B6 and 3A4 contribution resulted relevant at higher pesticide levels, very likely reached during poisoning episodes. These data are perfectly in line with those obtained with other OPTs, namely azinphos-methyl, chlorpyrifos, diazinon and parathion (Buratti et al., 2002 and 2003) , all presenting an aromatic ring in the molecule. Since malathion structure is different, being characterized by linear substituents at the thioether sulfur, it can be hypothesized that at actual exposure levels, although differing in their chemical structure, OPTs are mainly bioactivated by CYP1A2 and only to a lesser extent by CYP2B6. These isoforms can be regarded as good candidates as metabolic biomarkers of susceptibility. Indeed, individuals with high levels of CYP1A2, readily inducible by smoking, caffeine and aromatic amines, or bearing variant CYP2B6 alleles, would be expected to produce higher oxon levels and consequently to be differently susceptible to adverse effects induced by this class of pesticides.
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